[{"address1": "50 rue de Dijon", "city": "Daix", "zip": "21121", "country": "France", "phone": "33 3 80 44 75 00", "website": "https://inventivapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-\u00df, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.", "fullTimeEmployees": 84, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pierre  Broqua Ph.D.", "age": 63, "title": "Co-Founder", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 441605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martine  Zimmermann Pharm.D.", "age": 56, "title": "Executive VP of Regulatory Affairs & Quality Assurance", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 71859, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Obenshain", "age": 51, "title": "CEO & Director", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean  Volatier", "age": 60, "title": "Deputy GM & CFO", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Duranson L.L.M.", "age": 51, "title": "General Counsel", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nathalie  Harroy", "age": 58, "title": "Head of Human Resources", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pascaline  Clerc Ph.D.", "age": 44, "title": "Executive Vice President of External and Corporate Affairs", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason A. Campagna M.D., Ph.D.", "age": 59, "title": "President of Research and Development & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nazira  Amra M.D.", "title": "Chief Commercial Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.32, "open": 6.3, "dayLow": 5.9, "dayHigh": 6.32, "regularMarketPreviousClose": 6.32, "regularMarketOpen": 6.3, "regularMarketDayLow": 5.9, "regularMarketDayHigh": 6.32, "payoutRatio": 0.0, "beta": 0.771, "forwardPE": -4.991896, "volume": 519322, "regularMarketVolume": 519322, "averageVolume": 383142, "averageVolume10days": 668610, "averageDailyVolume10Day": 668610, "bid": 6.11, "ask": 6.03, "bidSize": 4, "askSize": 1, "marketCap": 1182262272, "fiftyTwoWeekLow": 2.231, "fiftyTwoWeekHigh": 7.983, "allTimeHigh": 19.064, "allTimeLow": 1.53, "priceToSalesTrailing12Months": 69.667786, "fiftyDayAverage": 4.9842, "twoHundredDayAverage": 4.370295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 867176832, "profitMargins": 0.0, "floatShares": 101348327, "sharesOutstanding": 191925703, "sharesShort": 157548, "sharesShortPriorMonth": 87064, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.09544, "shortRatio": 0.38, "shortPercentOfFloat": 0.00090000004, "impliedSharesOutstanding": 191925703, "bookValue": -0.0766496, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -311064992, "trailingEps": -4.5, "forwardEps": -1.234, "enterpriseToRevenue": 51.101, "enterpriseToEbitda": -9.053, "52WeekChange": 1.4251969, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 6.16, "targetHighPrice": 26.0, "targetLowPrice": 8.8, "targetMeanPrice": 15.48375, "targetMedianPrice": 13.5, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 122513000, "totalCashPerShare": 0.881, "ebitda": -95789000, "totalDebt": 132798000, "quickRatio": 2.486, "currentRatio": 2.956, "totalRevenue": 16970000, "revenuePerShare": 0.192, "returnOnAssets": -0.56769, "grossProfits": 16153000, "freeCashflow": -77385752, "operatingCashflow": -91311000, "revenueGrowth": 1.052, "grossMargins": 0.95185995, "ebitdaMargins": 0.0, "operatingMargins": -9.91889, "financialCurrency": "EUR", "symbol": "IVA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Inventiva S.A. - American Depos", "longName": "Inventiva S.A.", "corporateActions": [], "postMarketTime": 1769818348, "regularMarketTime": 1769806802, "exchange": "NGM", "messageBoardId": "finmb_273516426", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.5316505, "regularMarketPrice": 6.16, "fiftyTwoWeekLowChange": 3.929, "fiftyTwoWeekLowChangePercent": 1.7610937, "fiftyTwoWeekRange": "2.231 - 7.983", "fiftyTwoWeekHighChange": -1.823, "fiftyTwoWeekHighChangePercent": -0.22836027, "fiftyTwoWeekChangePercent": 142.51968, "earningsTimestamp": 1774904400, "earningsTimestampStart": 1774904400, "earningsTimestampEnd": 1774904400, "earningsCallTimestampStart": 1743076800, "earningsCallTimestampEnd": 1743076800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.5, "epsForward": -1.234, "epsCurrentYear": -1.95629, "priceEpsCurrentYear": -3.1488173, "fiftyDayAverageChange": 1.1757998, "fiftyDayAverageChangePercent": 0.23590542, "twoHundredDayAverageChange": 1.7897048, "twoHundredDayAverageChangePercent": 0.4095158, "priceToBook": -80.365715, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "postMarketChangePercent": -0.9740251, "postMarketPrice": 6.1, "postMarketChange": -0.059999943, "regularMarketChange": -0.16000032, "regularMarketDayRange": "5.9 - 6.32", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 383142, "displayName": "Inventiva", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]